Lung as a metabolic organ.
スポンサーリンク
概要
- 論文の詳細を見る
Lung is not only a respiratory organ, but also a metabolic organ. Pulmonary vascular beds are extremely wide and this helps the lung to metabolite various vasoactive substances and to perform the gas exchange. Lungs can metabolite or inactivate PGE<SUB>2</SUB>, PGF<SUB>2α</SUB>, LTC<SUB>4</SUB>, LTD<SUB>4</SUB>, LTE<SUB>4</SUB>, serotonin, acetylcholine, bradykin, histamine and norepinephrine, and can produce histamine, serotonin, PAF, LTs, thromboxane A<SUB>2</SUB> and various PGs. Percentage inactivation of PGs and LTs are closely dependent to the width of pulmonary vascular beds. The percentage inactivation showed a marked decrease by increasing the dose of administered vasoactive substances, and also showed a marked decrease by clumping the left pulmonary artery trunk or by infusing glass beads (100μ of diameter) into the pulmonary artery.<BR>Chemical mediators, histamine and SRS-A can interact and regulate the release of other chemical mediator, and PAF accelerates the release of histamine, SRS-A, LTC<SUB>4</SUB> from passively sensitized guinea pig lung tissue following the antigen challenge.<BR>It is well known that cigarette smoking has diverse effects not only on the airway system but also on the pulmonary and systemic circulation.
- 日本炎症・再生医学会の論文
日本炎症・再生医学会 | 論文
- 新規キノリノン誘導体TA-270の炎症性気道疾患に対する効果
- Salazosulphapyridine, Predonizolone の好中球機能に及ぼす影響と Sodium ferrous citrate との併用効果についての検討
- Sodium ferrous citrate の好中球機能に及ぼす影響
- Mesalazine(Pentasa) の好中球機能に及ぼす影響と Sodium ferrous citrate(SFC) との併用効果についての検討
- 非ウイルスベクターによる細胞標的法の開発